Genentech, Inc. (DNA)

Company Executives

Powered by >>  Total Executives: 1172

Company Overview

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.

content provided by Dow Jones & Co., Inc. and may be inaccurate

News from bizjournals

• UCSF considers layoffs to pare its budget (San Francisco -- 03.01.10)
• FDA: Genentech HIV drug, booster combo may have side effects (San Francisco -- 02.23.10)
• Carl Icahn makes a run at Genzyme board (Boston -- 02.22.10)
• UCSF, Genentech strike $13M deal (San Francisco -- 02.22.10)
• Omar Haffar, founder, president and CEO, Presidio Pharmaceuticals (San Francisco -- 02.22.10)
• FDA approves Biogen Idec leukemia drug; company reports 4 more PML cases (Raleigh/Durham -- 02.19.10)
• Biogen drug OK'd for leukemia treatment (Boston -- 02.19.10)
• Slow-growing biomed sector in north state needs a hand (Sacramento -- 02.15.10)
• LIVESTRONG launches online/print magazine (Austin -- 02.09.10)
• Dana-Farber sells flu antibodies to Roche (Boston -- 02.08.10)

More stories from bizjournals

• Help
• Advertise
• Site Map
• Archive
• Contact Portfolio
• Contributors
• Newsletters
• RSS